BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11234363)

  • 1. MGMA data reveal higher revenues for heavily capitated groups.
    Capitation Manag Rep; 2001 Feb; 8(2):30, 17. PubMed ID: 11234363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capitation building momentum in latest MGMA group practice data.
    Capitation Manag Rep; 2003 May; 10(5):75-9. PubMed ID: 12800612
    [No Abstract]   [Full Text] [Related]  

  • 3. Shrinkage in risk contracting 'less than expected,' survey finds.
    Capitation Manag Rep; 2002 Jun; 9(6):88-91, 81. PubMed ID: 12154558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician compensation rising, but docs in capitated groups losing ground.
    Capitation Rates Data; 2001 Dec; 6(12):139-42. PubMed ID: 11793870
    [No Abstract]   [Full Text] [Related]  

  • 5. Capitated groups learning to manage risk, report shows.
    Capitation Rates Data; 2001 Jul; 6(7):74-7. PubMed ID: 11481809
    [No Abstract]   [Full Text] [Related]  

  • 6. Use MGMA data to benchmark revenues, costs under capitation.
    Capitation Manag Rep; 1999 Mar; 6(3):43-6. PubMed ID: 10351434
    [No Abstract]   [Full Text] [Related]  

  • 7. Capitation declines, but payer mix remains steady.
    Capitation Manag Rep; 2002 Sep; 9(9):136-9, 129. PubMed ID: 12325412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capitation report continues to refute other indicators.
    Capitation Rates Data; 2000 Sep; 5(9):102-4. PubMed ID: 11186333
    [No Abstract]   [Full Text] [Related]  

  • 9. Compensation monitor. Risk contracts help medical groups' bottom line.
    Manag Care; 2008 Dec; 17(12):11. PubMed ID: 19127759
    [No Abstract]   [Full Text] [Related]  

  • 10. Zero-based budgeting eases the transition to specialty capitation.
    Capitation Manag Rep; 1999 Feb; 6(2):22-5. PubMed ID: 10350830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identify cost drivers to bring cap contracts into the black.
    Capitation Manag Rep; 2003 Aug; 10(8):105-9. PubMed ID: 12966694
    [No Abstract]   [Full Text] [Related]  

  • 12. With nearly all revenue at risk, CA group thrives.
    Capitation Rates Data; 2003 Oct; 8(10):111-2. PubMed ID: 14621546
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of negotiating leverage dooms this multispecialty group to poor performance.
    Capitation Manag Rep; 2000 Oct; 7(10):155-6, 145. PubMed ID: 11188074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texas PMPM rates, utilization data reveal wide fluctuations.
    Capitation Rates Data; 1999 Jan; 4(1):5-6. PubMed ID: 10345874
    [No Abstract]   [Full Text] [Related]  

  • 15. Capitation's technical component: a potential deal-breaker.
    Capitation Manag Rep; 1999 Feb; 6(2):20-2. PubMed ID: 10350829
    [No Abstract]   [Full Text] [Related]  

  • 16. A mixed bag of PMPM rates for this OK multispecialty group.
    Capitation Manag Rep; 2000 Nov; 7(11):166-7. PubMed ID: 11188276
    [No Abstract]   [Full Text] [Related]  

  • 17. Check these rates for across-the-board comparison of California groups.
    Capitation Rates Data; 2004 Aug; 9(8):89-90. PubMed ID: 15487583
    [No Abstract]   [Full Text] [Related]  

  • 18. Do you have adequate reserves for your capitated contracts?
    Capitation Manag Rep; 1999 Nov; 6(11):166-9. PubMed ID: 10724582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capitated groups need to 'get back to basics'.
    Soroka L
    Capitation Manag Rep; 2003 May; 10(5):73-5. PubMed ID: 12800611
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing services and risk in claims payments.
    Wakefield B; LaTulippe D
    Health Manag Technol; 1999 Nov; 20(10):18. PubMed ID: 10622869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.